Literature DB >> 18824163

Comparison and validation of point of care lactate meters as a replacement for fetal pH measurement.

Robert V Ridenour1, Ravi P Gada, Brian C Brost, Brad S Karon.   

Abstract

OBJECTIVE: To validate a point of care lactate device to replace fetal pH measurement. STUDY DESIGN AND METHODS: Cord blood samples drawn immediately following delivery were tested on the Nova Lactate Plus and ARKRAY Lactate Pro, the Corometrics 220 pH System, and the Vitros chemistry analyzer (used as lactate reference).
RESULTS: Nova demonstrated a constant positive bias relative to the lactate reference method; while the Lactate Pro correlated well with the reference method up to 6 mmol/L. Receiver operating characteristic (ROC) curve analysis showed optimal sensitivity and specificity for predicting pH<7.20 at lactate values of 6.8 mmol/L for the Nova and 4.8 mmol/L for the Lactate Pro.
CONCLUSION: Using Lactate Pro the best cut-off for predicting pH< or =7.20 was 4.8 mM; which coincides with current clinical cut-offs. Thus any lactate device that correlates well with the laboratory reference method can be used with a clinical cut-off of 4.8 mmol/L.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18824163     DOI: 10.1016/j.clinbiochem.2008.08.088

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  9 in total

1.  Temporal sequence of major biochemical events during blood bank storage of packed red blood cells.

Authors:  Brad S Karon; Camille M van Buskirk; Elizabeth A Jaben; James D Hoyer; David D Thomas
Journal:  Blood Transfus       Date:  2012-03-28       Impact factor: 3.443

2.  Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications.

Authors:  Marilyn J Crain; Paige L Williams; Ray Griner; Katherine Tassiopoulos; Jennifer S Read; Lynne M Mofenson; Kenneth C Rich
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

3.  Effect of Oxygen vs Room Air on Intrauterine Fetal Resuscitation: A Randomized Noninferiority Clinical Trial.

Authors:  Nandini Raghuraman; Leping Wan; Lorene A Temming; Candice Woolfolk; George A Macones; Methodius G Tuuli; Alison G Cahill
Journal:  JAMA Pediatr       Date:  2018-09-01       Impact factor: 16.193

4.  Failure to clear elevated lactate predicts 24-hour mortality in trauma patients.

Authors:  Zachary D W Dezman; Angela C Comer; Gordon S Smith; Mayur Narayan; Thomas M Scalea; Jon Mark Hirshon
Journal:  J Trauma Acute Care Surg       Date:  2015-10       Impact factor: 3.313

5.  Prehospital lactate improves accuracy of prehospital criteria for designating trauma activation level.

Authors:  Joshua B Brown; E Brooke Lerner; Jason L Sperry; Timothy R Billiar; Andrew B Peitzman; Francis X Guyette
Journal:  J Trauma Acute Care Surg       Date:  2016-09       Impact factor: 3.313

6.  Attitudes towards the implementation of universal umbilical artery lactate analysis in a South African district hospital.

Authors:  Emma R Allanson; Kate Grobicki; Robert C Pattinson; Jan E Dickinson
Journal:  BMC Pregnancy Childbirth       Date:  2016-07-18       Impact factor: 3.007

7.  A method-comparison study regarding the validity and reliability of the Lactate Plus analyzer.

Authors:  Sarah Hart; Kathryn Drevets; Micah Alford; Amanda Salacinski; Brian E Hunt
Journal:  BMJ Open       Date:  2013-02-27       Impact factor: 2.692

8.  Lactate point-of-care testing for acidosis: Cross-comparison of two devices with routine laboratory results.

Authors:  Remco van Horssen; Teska N Schuurman; Monique J M de Groot; Bernadette S Jakobs
Journal:  Pract Lab Med       Date:  2015-12-24

Review 9.  Sensors for Fetal Hypoxia and Metabolic Acidosis: A Review.

Authors:  Gerard Cummins; Jessica Kremer; Anne Bernassau; Andrew Brown; Helen L Bridle; Holger Schulze; Till T Bachmann; Michael Crichton; Fiona C Denison; Marc P Y Desmulliez
Journal:  Sensors (Basel)       Date:  2018-08-13       Impact factor: 3.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.